ACET FY 2012 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$68M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$444M+7.7% YoY

Gross Profit

$82M18.5% margin

Operating Income

$25M5.7% margin

Net Income

$17M3.8% margin

EPS (Diluted)

$11.52

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$299M

Total Liabilities

$131M

Stockholders' Equity

$168M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$444M	$412M	+7.7%
Gross Profit	$82M	$66M	+24.6%
Operating Income	$25M	$17M	+53.3%
Net Income	$17M	$9M	+89.4%